Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgeryChristian Kollmannsberger, Siamak Daneshmand, Alan So, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2012
Thymoma: a population-based study of the management and outcomes for the province of British ColumbiaCaroline Mariano, Diana N Ionescu, Winson Y Cheung, et al.International Journal of Radiation Oncology, Biology, Physics|March 7, 2017
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate CancerW James Morris, Scott Tyldesley, Sree Rodda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancerKim N Chi, Martin E Gleave, Ladan Fazli, et al.Lung Cancer (Amsterdam, Netherlands)|November 7, 2013
A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced diseaseCaroline Mariano, Ian Bosdet, Aly Karsan, et al.Cancer|January 8, 2009
A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancerDaniel Y C Heng, Kim N Chi, Nevin Murray, et al.Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.Clinical Lung Cancer|November 13, 2010
A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancerCharles Butts, R Nevin Murray, Colum J Smith, et al.Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Population-based outcomes for small cell lung cancer: impact of standard management policies in British ColumbiaJanessa J Laskin, Sara C Erridge, Andrew J Coldman, et al.International Journal of Radiation Oncology, Biology, Physics|April 24, 2017
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate CancerSree Rodda, Scott Tyldesley, W James Morris, et al.Pageof 5